BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2371923)

  • 1. Peripheral and central opioid activity in the analgesic potency of morphine.
    Arrigo-Reina R
    Agents Actions; 1990 Apr; 30(1-2):210-2. PubMed ID: 2371923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histaminergic mechanisms in clonidine induced analgesia in rat tail-flick test.
    Arrigo-Reina R; Chiechio S
    Inflamm Res; 1995 Jan; 44(1):21-3. PubMed ID: 7664025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
    Calcagnetti DJ; Holtzman SG
    Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of stress and beta-funal trexamine pretreatment on morphine analgesia and opioid binding in rats.
    Adams JU; Andrews JS; Hiller JM; Simon EJ; Holtzman SG
    Life Sci; 1987 Dec; 41(26):2835-44. PubMed ID: 2826950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
    Adams JU; Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.
    Chen XH; Liu-Chen LY; Tallarida RJ; Geller EB; de Riel JK; Adler MW
    Neurochem Res; 1996 Nov; 21(11):1363-8. PubMed ID: 8947926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced changes in the analgesic and thermic effects of morphine administered centrally.
    Appelbaum BD; Holtzman SG
    Brain Res; 1985 Dec; 358(1-2):303-8. PubMed ID: 4075121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of morphine analgesia in rats given a single exposure to restraint stress immobilization.
    Calcagnetti DJ; Holtzman SG
    Pharmacol Biochem Behav; 1992 Feb; 41(2):449-53. PubMed ID: 1574536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphimine.
    Paronis CA; Waddell AB; Holtzman SG
    Pharmacol Biochem Behav; 1993 Dec; 46(4):813-7. PubMed ID: 8309960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic opioid antagonist treatment facilitates nonopioid, stress-induced analgesia.
    Yoburn BC; Truesdell LS; Kest B; Inturrisi CE; Bodnar RJ
    Pharmacol Biochem Behav; 1987 Jul; 27(3):525-7. PubMed ID: 2821554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD; Bayer BM
    Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine-induced straub tail response: mediated by central mu2-opioid receptor.
    Nath C; Gupta MB; Patnaik GK; Dhawan KN
    Eur J Pharmacol; 1994 Sep; 263(1-2):203-5. PubMed ID: 7821354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting restraint stress-induced potentiation of morphine analgesia.
    Calcagnetti DJ; Holtzman SG
    Brain Res; 1990 Dec; 537(1-2):157-62. PubMed ID: 2085771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice.
    Suh HH; Fujimoto JM; Tseng LL
    Eur J Pharmacol; 1989 Sep; 168(1):61-70. PubMed ID: 2531093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of rat thermal responses to morphine by alpha-FMH suggests a role for neural histamine in morphine tolerance.
    Arrigo-Reina R; Spadaro C
    Agents Actions; 1990 Apr; 30(1-2):213-5. PubMed ID: 2371924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restraint stress potentiates analgesia induced by 5'-N-ethylcarboxamidoadenosine: comparison with morphine.
    Woolfolk DR; Holtzman SG
    Eur J Pharmacol; 1993 Aug; 239(1-3):177-82. PubMed ID: 8223892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.